Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03045575 · ClinicalTrials.gov registry record
Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 65
- Enrollment target
NCT03045575: Completed study, sponsored by University of California, San Francisco.
NCT03045575 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03045575 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This is a prospective observational study designed to determine the feasibility and acceptability of objectively measuring physical activity, sedentary time, and sleep using the Fitbit Charge HR wristband. 50 patients who have been diagnosed with breast cancer and are planning to initiate chemotherapy will be invited to participate in this study, and we will measure general and breast-specific quality-of-life using Patient-Reported Outcomes Measurement Information System (PROMIS) measures for 3-6 months after completion of chemotherapy.
Primary Outcome
Adherence, defined at the percentage of weeks that a participant successfully syncs their Fitbit at least once a week during the course of the study, will be reported as a point estimate and 95% confidence interval
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-08-02 |
| Est. Completion | 2018-12-31 |
What the finished NCT03045575 record still lists
NCT03045575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03045575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03045575 about?
NCT03045575 is a clinical study titled "Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer". This is a prospective observational study designed to determine the feasibility and acceptability of objectively measuring physical activity, sedentary time, and sleep using the Fitbit Charge HR wristband. 50 patients who have been diagnosed with breast cancer and are planning to initiate chemothera...
What is the current status of trial NCT03045575?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2016-08-02. Estimated completion is 2018-12-31.
Who is sponsoring clinical trial NCT03045575?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI